Tag Archives: schizophrenia

Forum and CIAS

Forum Pharmaceuticals (formerly EnVivo) announced today that their two Phase III trials of FRM-6124 in CIAS (Cognitive Impairment Associated with Schizophrenia) failed to hit their co-primary endpoints.   No details were provided, but there apparently are signs of a treatment effect … Continue reading

Posted in Biotech, Science | Tagged , , | 1 Comment

Roche Hits First Two of Three

Roche had been approaching a Trifecta of datasets and decision points that would determine whether their steadfast focus on innovative R&D in neuroscience would be sustained. Now, it seems certain that it will be, because the Company had success in … Continue reading

Posted in Big Pharma | Tagged , , , , , , | Leave a comment

Of Persistence and Ethics in Phase III

Persistence paid off for Lundbeck and Takeda, whose first Phase III program for their antidepressant Lu AA21004 failed. With revised dosing, they ran another extensive set of pivotal trials, have announced that they will be filing for regulatory approval in … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , , , , , | 1 Comment